MRC2 and central nervous system cancer: We excluded genetic and epigenetic regulation as no genomic amplification of the Endo180 locus (MRC2) at 17q23 was detected in 11 glioma cell lines [25] and the Endo180 promoter was unmethylated in all cell lines tested, with the exception of UW479 (Figure S1).